Compare Ginkgo Bioworks Holdings Inc (DNA) vs iShares JPMorgan USD Emerging Markets Bond ETF (EMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs iShares JPMorgan USD Emerging Markets Bond ETF — how do they compare? Ginkgo Bioworks Holdings Inc trades at $9.06 (market cap $591.19M), while iShares JPMorgan USD Emerging Markets Bond ETF trades at $95.75. The key difference: iShares JPMorgan USD Emerging Markets Bond ETF is trading nearer its 52-week high, Ginkgo Bioworks Holdings Inc nearer its low. Which is the better fit depends on your goals.
| DNA | EMB | |
|---|---|---|
Market Cap | $591.19M | — |
Sector | Health | Fixed Income |
52-Week High | $16.14 | $97.74 |
52-Week Low | $5.48 | $91.52 |
Enterprise Value | $628.43M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About iShares JPMorgan USD Emerging Markets Bond ETF
EMB invests in U.S. dollar-denominated sovereign debt from emerging market countries. It provides exposure to government bonds from dozens of nations like Turkey, Mexico, and Brazil, offering a way to seek higher yields and geographic diversification.
Read more on EMB →
